IBDEI1IO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26921,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND/LOC BRIEF
 ;;^UTILITY(U,$J,358.3,26921,1,4,0)
 ;;=4^854.02
 ;;^UTILITY(U,$J,358.3,26921,2)
 ;;=^274713
 ;;^UTILITY(U,$J,358.3,26922,0)
 ;;=854.03^^158^1737^15
 ;;^UTILITY(U,$J,358.3,26922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26922,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND/LOC MOD
 ;;^UTILITY(U,$J,358.3,26922,1,4,0)
 ;;=4^854.03
 ;;^UTILITY(U,$J,358.3,26922,2)
 ;;=^274714
 ;;^UTILITY(U,$J,358.3,26923,0)
 ;;=854.04^^158^1737^17
 ;;^UTILITY(U,$J,358.3,26923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26923,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND/LOC PROLONG
 ;;^UTILITY(U,$J,358.3,26923,1,4,0)
 ;;=4^854.04
 ;;^UTILITY(U,$J,358.3,26923,2)
 ;;=^274715
 ;;^UTILITY(U,$J,358.3,26924,0)
 ;;=854.05^^158^1737^14
 ;;^UTILITY(U,$J,358.3,26924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26924,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND/LOC DEEP
 ;;^UTILITY(U,$J,358.3,26924,1,4,0)
 ;;=4^854.05
 ;;^UTILITY(U,$J,358.3,26924,2)
 ;;=^274716
 ;;^UTILITY(U,$J,358.3,26925,0)
 ;;=854.06^^158^1737^18
 ;;^UTILITY(U,$J,358.3,26925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26925,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND/LOC TIME NOS
 ;;^UTILITY(U,$J,358.3,26925,1,4,0)
 ;;=4^854.06
 ;;^UTILITY(U,$J,358.3,26925,2)
 ;;=^274717
 ;;^UTILITY(U,$J,358.3,26926,0)
 ;;=854.09^^158^1737^12
 ;;^UTILITY(U,$J,358.3,26926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26926,1,3,0)
 ;;=3^TBI NEC-NOS W/O OPN WND W/ CONCUSSION
 ;;^UTILITY(U,$J,358.3,26926,1,4,0)
 ;;=4^854.09
 ;;^UTILITY(U,$J,358.3,26926,2)
 ;;=^274718
 ;;^UTILITY(U,$J,358.3,26927,0)
 ;;=20600^^159^1738^5^^^^1
 ;;^UTILITY(U,$J,358.3,26927,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26927,1,2,0)
 ;;=2^Drain/Inject, Joint/Bursa
 ;;^UTILITY(U,$J,358.3,26927,1,3,0)
 ;;=3^20600
 ;;^UTILITY(U,$J,358.3,26928,0)
 ;;=20605^^159^1738^1^^^^1
 ;;^UTILITY(U,$J,358.3,26928,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26928,1,2,0)
 ;;=2^Asp/Inj Interm Jt(Ac/Wrist/Ankle
 ;;^UTILITY(U,$J,358.3,26928,1,3,0)
 ;;=3^20605
 ;;^UTILITY(U,$J,358.3,26929,0)
 ;;=20610^^159^1738^2^^^^1
 ;;^UTILITY(U,$J,358.3,26929,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26929,1,2,0)
 ;;=2^Asp/Inj Maj Jt (Should/Hip/Knee
 ;;^UTILITY(U,$J,358.3,26929,1,3,0)
 ;;=3^20610
 ;;^UTILITY(U,$J,358.3,26930,0)
 ;;=20550^^159^1738^6^^^^1
 ;;^UTILITY(U,$J,358.3,26930,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26930,1,2,0)
 ;;=2^Inject Tendon/Ligament/Cyst 
 ;;^UTILITY(U,$J,358.3,26930,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,26931,0)
 ;;=J1100^^159^1738^4^^^^1
 ;;^UTILITY(U,$J,358.3,26931,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26931,1,2,0)
 ;;=2^Dexamethasone Sodium Phos 1 mg
 ;;^UTILITY(U,$J,358.3,26931,1,3,0)
 ;;=3^J1100
 ;;^UTILITY(U,$J,358.3,26932,0)
 ;;=J0800^^159^1738^3^^^^1
 ;;^UTILITY(U,$J,358.3,26932,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26932,1,2,0)
 ;;=2^Corticotropin Inj up to 40 units
 ;;^UTILITY(U,$J,358.3,26932,1,3,0)
 ;;=3^J0800
 ;;^UTILITY(U,$J,358.3,26933,0)
 ;;=J1040^^159^1738^7^^^^1
 ;;^UTILITY(U,$J,358.3,26933,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26933,1,2,0)
 ;;=2^Methylprednisolone 80 Mg Inj
 ;;^UTILITY(U,$J,358.3,26933,1,3,0)
 ;;=3^J1040
 ;;^UTILITY(U,$J,358.3,26934,0)
 ;;=20552^^159^1738^8^^^^1
 ;;^UTILITY(U,$J,358.3,26934,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26934,1,2,0)
 ;;=2^Trigger Point(s) Inj,1-2 Muscles
 ;;^UTILITY(U,$J,358.3,26934,1,3,0)
 ;;=3^20552
 ;;^UTILITY(U,$J,358.3,26935,0)
 ;;=20553^^159^1738^9^^^^1
 ;;^UTILITY(U,$J,358.3,26935,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI1IO
